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Abstract
Tyrolean Grey cattle represent a local breed with a population size of ,5000 registered cows. In 2003, a previously unknown
neurological disorder was recognized in Tyrolean Grey cattle. The clinical signs of the disorder are similar to those of bovine
progressive degenerative myeloencephalopathy (weaver syndrome) in Brown Swiss cattle but occur much earlier in life. The
neuropathological investigation of an affected calf showed axonal degeneration in the central nervous system (CNS) and
femoral nerve. The pedigrees of the affected calves suggested a monogenic autosomal recessive inheritance. We localized
the responsible mutation to a 1.9 Mb interval on chromosome 16 by genome-wide association and haplotype mapping.
The MFN2 gene located in this interval encodes mitofusin 2, a mitochondrial membrane protein. A heritable human axonal
neuropathy, Charcot-Marie-Tooth disease-2A2 (CMT2A2), is caused by MFN2 mutations. Therefore, we considered MFN2 a
positional and functional candidate gene and performed mutation analysis in affected and control Tyrolean Grey cattle. We
did not find any non-synonymous variants. However, we identified a perfectly associated silent SNP in the coding region of
exon 20 of the MFN2 gene. This SNP is located within a putative exonic splice enhancer (ESE) and the variant allele leads to
partial retention of the entire intron 19 and a premature stop codon in the aberrant MFN2 transcript. Thus we have
identified a highly unusual splicing defect, where an exonic single base exchange leads to the retention of the preceding
intron. This splicing defect represents a potential explanation for the observed degenerative axonopathy. Marker assisted
selection can now be used to eliminate degenerative axonopathy from Tyrolean Grey cattle.
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Introduction
Spontaneous mutants in domestic animals provide insights on
genotype-phenotype correlations, which are relevant for biomed-
ical research [1]. Disorders of the nervous system may be caused
by trauma, infectious agents, toxins, metabolic aberrations, and
also genetic defects. Many inherited disorders of the nervous
system are known in domestic animals including cattle [2]. Strong
inbreeding in the bovine population has increased the risk of the
occurrence of genetic diseases. The most common mode of
transmission of genetic defects in cattle is monogenic autosomal
recessive inheritance [2,3]. Calves with recessive defects are
typically the consequence of inbreeding. This is common in
livestock breeding programs when female descendants of artificial
insemination sires are mated with test bulls that are also direct
descendents of the former sires. Recessive genetic diseases become
apparent many years after the initial mutation event. In cattle,
most of the known recessive defects became apparent 5 to 10
generations after the founder animal, which corresponds to the
time after which male and female descendants of the original
carrier are mated. During the latent phase the deleterious allele
might have been widely spread throughout the population
explaining sudden outbreaks with many affected animals appear-
ing simultaneously [3].
Currently, there are six known examples of inherited neuro-
logical/neuromuscular diseases of cattle where the molecular basis
has been elucidated and gene tests for selection against the
deleterious mutation are available. Three of these defects segregate
in the international Brown Swiss cattle population. The bovine
progressive degenerative myeloencephalopathy (weaver syndrome)
is characterized by axonal degeneration and vacuolation of the
white matter of the spinal cord and degenerative changes or
numeric reduction of the Purkinje cells in the cerebellum. Affected
animals become clinically apparent at about 6–8 months of age.
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in the year 1993, but until now the causative mutation has not
been identified [4]. Spinal muscular atrophy (SMA) is character-
ized by severe muscular atrophy, progressive quadriparesis, and
sternal recumbency due to degeneration of ventral motor neurons
in the spinal cord. First symptoms of SMA appear at 3–4 weeks of
age and this progressive lethal disease is caused by a nonsense
mutation of FVT1 [5]. Spinal dysmyelination (SDM) is character-
ized by pathological reduction of myelin in specific tracts of the
spinal cord and severe neurological symptoms where the causative
mutation in SPAST has recently been identified [6]. Affected calves
usually die or are euthanized during the first week of life. In
Belgian Blue cattle the causative mutations for congenital
muscular dystony type 2 (CMD2) has been identified in the
SLC6A5 gene encoding an ion channel for the neurotransmitter
glycine [3]. A clinically related phenotype termed CMD1 in
Belgian Blue cattle or pseudomyotonia in Chianina cattle is caused
by two different mutations in the ATPA2A1 gene encoding a
calcium pump in the sarcoplasmic reticulum of skeletal muscle
[3,7,8]. Other cattle breeds also show inherited diseases affecting
the nervous systems but the molecular basis is unclear [2].
Tyrolean Grey cattle represent a local breed with a population
size of ,5000 registered cows. In 2003, a previously unknown
neurological disorder was recognized in Tyrolean Grey cattle by
the veterinary practitioner Dr. Florian Demetz. The clinical signs
of the so-called Demetz syndrome are similar to those of weaver
syndrome in Brown Swiss cattle but occur earlier in life. The
pedigrees of the affected calves suggest a monogenic autosomal
recessive mode of inheritance and nearly all affected animals trace
back to a single female. The neuropathology of this disease is
characterized by an axonal degeneration targeting primarily the
spinal cord. This study reports the positional cloning and
subsequent identification of a candidate causative mutation.
Results
Clinical and neuropathological findings
We obtained one affected calf for clinical and neuropathological
examination, which is described in more detail elsewhere [9].
Spinal ataxia was the most prominent feature (Figure 1). The
animal showed mild ambulatory paraparesis with moderate to
severe ataxia most pronounced in the pelvic limbs. All four
extremities were affected, but gait abnormalities and conscious
proprioceptive deficits were markedly more severe in the pelvic
than in the thoracic limbs. The calf often stood with a wide stance
in all limbs, otherwise it lost balance after a few seconds and fell to
the ground (Video S1). According to the Tyrolean Grey cattle
breeding organizations affected calves show progressive ataxia in
the hind legs, starting at the age of 1 to 1.5 months. Progression of
the symptoms eventually leads to recumbency. Most affected
animals have to be slaughtered between 8 and 10 months of age.
The neuropathological examination of this affected calf revealed
prominent bilateral-symmetrical (Wallerian type) axonal degener-
ation/loss and astrogliosis targeting primarily the dorsal spinocer-
ebellar tract and the gracile fascicle of the spinal cord. Scattered
degenerating axons were observed in the remaining white matter
tracts of the spinal cord, in the white matter of the brain and in the
femoral nerve. Additionally, swelling and chromatolysis of most
neurons in the red nucleus and occasional motor neurons in
brainstem nuclei and spinal cord ventral horns was observed.
Lesions were compatible with a multisystem axonal degeneration
(‘‘long tract degeneration’’) and their patterntogether with neuronal
changes suggest a distal axonopathy due to primary neuronal
metabolic dysfunction. We found a similar degenerative axono-
pathy in archived material from three other Tyrolean Grey calves.
Analysis of the mode of inheritance
We identified 49 cases in Tyrolean Grey cattle and obtained
DNA samples from 44 of them. The pedigree records were
consistent with a monogenic autosomal recessive inheritance
Figure 1. Phenotype of degenerative axonopathy in Tyrolean
Grey cattle. (A) Moderate to severe spinal ataxia in an affected calf.
Gait abnormalities and proprioceptive deficits were present in all limbs,
but were markedly more pronounced in the hind than in the front
limbs. (B) Thoracic spinal cord of a calf affected with degenerative
axonopathy. Bilateral-symmetrical axonal loss leading to reduction of
axonal density in the dorsal spinocerebellar tract (arrows) and gracile
fascicle (arrowheads). Modified Bielschowsky staining, 12.56 magnifi-
cation. (C) Swollen and chromatolytic neuron (arrow) adjacent to a
normal neuron (arrowhead) in the mesencephalic red nucleus. The
nucleus is displaced at the periphery and pyknotic. H&E, 4006
magnification. (D) Femoral nerve. Wallerian type axonal degeneration
and axonal loss: digestion chambers containing axonal and myelin
fragments (arrows), proliferation of Schwann cells forming bands of
Bu ¨ngner. H&E, 4006 magnification. (E, F, G) Corresponding tissue
sections of a normal age-matched control animal.
doi:10.1371/journal.pone.0018931.g001
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occurred before the year 1972.
Mapping of the causative mutation
We genotyped 54,001 evenly spaced SNPs on 14 affected calves
and 27 controls. After removing 19,506 non-informative markers
34,495 SNPs were used for the subsequent analyses. In a genome-
wide association study (GWAS) several SNPs on BTA16 were
found to be associated with degenerative axonopathy (Figure 2A).
The associated SNPs were spread over a 25 Mb region. The best-
associated SNP had a genome-wide corrected p-value of 9.9610
25
(Figure 2B). No other region in the genome showed genome-wide
associated SNPs.
Subsequently, we applied a homozygosity mapping approach
to fine-map the region containing the degenerative axonopathy
mutation. Based on the pedigree records we hypothesized that
the affected calves most likely were inbred to one single founder
animal (Figure S1). Under this scenario the affected individuals
were expected to be identical by descent (IBD) for the causative
mutation and flanking chromosomal segments. We analyzed the
cases for extended regions of homozygosity with simultaneous
allele sharing. Only one genome region fulfilled our search
criteria. On BTA 16 all 14 affected genotyped calves were
homozygous and shared identical alleles over 46 SNP markers
corresponding to a 2.88 Mb interval from 36.87–39.75 Mb
(Figure 2C).
In order to further narrow down the critical interval, we then
examined 18 obligate carriers for the mutation and reconstructed
one copy of the disease-associated haplotype in each animal. One
of the carriers showed a recombination event, which allowed us to
narrow down the critical interval harboring the causative mutation
to 1.90 Mb from 37.85–39.75 Mb (Figure 2C).
Identification and characterization of functional
candidate genes
As the annotation of the bovine genome is still far from perfect,
we inferred the gene content of the mapped interval from the
corresponding human interval (Figure 2D). The mapped degen-
erative axonopathy interval corresponds to a segment from 10.7–
12.7 Mb on HSA 1. This human interval contains 34 annotated
genes and 4 hypothetical loci (NCBI MapViewer, build 37.1). A
careful inspection of these genes and database searches of their
presumed function revealed the genes encoding TAR DNA
binding protein (TARDBP), methylenetetrahydrofolate reductase
(MTHFR), and mitofusin 2 (MFN2) as possible functional
candidate genes within the critical interval. Mutations in any of
these three genes can cause neurological disease in humans [10].
Genomic mutation analysis
Initially, we sequenced all coding exons of the TARDBP,
MTHFR, and MFN2 genes in three affected and five control
animals. We did not find any polymorphism in the six exons of the
TARDBP gene and its expression was similar in tissue samples from
a case and a control animal (Figure S2). In the 12 exons and
adjacent intron regions of the MTHFR gene, we identified 11
polymorphisms but none of them was perfectly associated with the
disease in the eight animals of our mutation analysis. In the MFN2
gene, we identified four SNPs in the coding sequence (Table S1).
As all of these SNPs were translationally silent, we re-sequenced a
contiguous genomic interval of more than 37 kb spanning the
complete MFN2 gene including 8 kb of 59-flanking sequence and
parts of the preceding gene. In this 37 kb interval we identified
174 polymorphisms between the eight Tyrolean Grey cattle and
the bovine reference genome sequence (Table S1). Only one of
these polymorphisms, the synonymous SNP c.2229C.T located
in exon 20 of the MFN2 gene, was perfectly associated with the
phenotype in the eight animals. We then genotyped 485 Tyrolean
Grey cattle for this SNP and found again an almost perfect
association of the mutant T-allele with the degenerative axono-
pathy phenotype (Table 1). All cases were homozygous for the
mutant allele and none of the controls were homozygous for this
allele. Only one reported carrier yielded a discordant genotyping
result and was homozygous for the wildtype allele, which is most
likely due to a phenotyping error of the affected offspring (Table 1).
The mutant allele was absent from 83 healthy cattle from 10
genetically diverse breeds. Southern blots from an affected and a
control calf yielded the expected bands and did not indicate any
copy number changes or structural variations of the MFN2 gene
(data not shown).
Transcript analysis
As the associated MFN2 c.2229C.T polymorphism did not
change the encoded amino acid sequence, we analyzed the MFN2
transcripts in four different tissues from an affected calf and a
control animal, which was homozygous wildtype at the
c.2229C.T SNP. Northern blotting revealed the expected
4.6 kb band in both animals. RT-PCR experiments showed that
similar to human two alternatively spliced MFN2 transcripts are
expressed in cattle. The two transcript isoforms differ by the
presence or absence of the untranslated 85 bp exon 3, which is not
resolved in the Northern blot. The two alternatively spliced
transcripts encode identical proteins. Both transcript isoforms were
detected in the affected and control calf.
In the affected calf, there was, however, also an additional
larger transcript of 5.8 kb present in all investigated tissues
(Figure 3A). The mRNA expression level of MFN2 varied across
the investigated tissues with the highest expression seen in brain
and about four-fold lower expression in peripheral nerves
(Figure 3B). The total amount of MFN2 transcript was
comparable between the affected and the control calf. However,
in the affected calf, depending on the tissue between 20% and
45% of the MFN2 transcripts corresponded to the 5.8 kb
transcript. We performed RT-PCR on the RNA samples from
both animals and sequenced the products to confirm their
identity. The additional 5.8 kb band in the Northern blot
corresponds to an MFN2 transcript, in which the 1,205 nt intron
19 is retained (Figure 3C). As there is a stop codon immediately at
the beginning of intron 19, the aberrant 5.8 kb transcript encodes
a C-terminally truncated protein, which is predicted to lack 22
amino acids compared to the wildtype MFN2 protein (p.N736X;
Figure S3). Transcript analysis in a heterozygous carrier animal
revealed that the intron retention occurs only in cis on transcripts
with the mutant T-allele, but not in trans on the wildtype
transcripts (Figure S4).
Protein Analysis
The molecular masses of wild-type bovine MFN2 and its
putative C- terminally truncated variant were calculated at
86.3 kDa and 83.7 kDa, respectively. To investigate whether the
aberrant transcript is translated, we analyzed nervous tissues of the
affected calf and the control calf by Western immunoblot using a
polyclonal anti-MFN2 rabbit antiserum. While in the control calf
only the full-length wild-type MFN2 was identified, the affected
calf showed full-length MFN2 as well as a faint band of slightly
lower molecular mass, which was in the range of that expected for
the truncated MFN2 (Figure 4).
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Mitochondria were well-delineated by an outer membrane and
the inner membrane displayed typical cristae. Though basically
tubular in shape, branching of mitochondria appeared to be more
prominent in an affected calf as compared to a control animal
(Figure 5). This observation was particularly noticeable in striated
muscle fibers.
Discussion
In this study we performed a comprehensive genetic investi-
gation of inherited degenerative axonopathy in Tyrolean Grey
cattle. With the availability of genome sequences and high-
density SNP genotyping microarrays the mapping of causative
mutations for monogenic traits in domestic animal species has
become a fairly straightforward procedure [3,11]. Thus, we could
quickly identify a relatively small interval for the degenerative
axonopathy mutation in Tyrolean Grey cattle containing less
than 40 genes. The MFN2 gene stood out as a good functional
and positional candidate gene. Based on the recessive mode of
inheritance, we expected to find a loss-of-function mutation
affecting the coding sequence of MFN2. Therefore, we initially
did not rate the synonymous c.2229C.T SNP as promising
candidate causative mutation. Only when we systematically
screened the complete MFN2 gene including the complete 59-
flanking sequence up to the next flanking gene, we realized that
c.2229C.T was the only MFN2 variant that showed the
expected association to the degenerative axonopathy phenotype.
This mutation is located at the 25
th nucleotide of the last exon,
which did not immediately strike us as potentially important
region for splicing. However, the comprehensive analysis of
genomic DNA and mRNA by different experimental approaches
including the traditional Northern blot clearly demonstrated that
the c.2229C.T variant does indeed lead to a partial retention of
the entire intron 19. During the last years it has become
increasingly clear that splice site recognition in mammals is not
only dependent on the conserved 59-a n d3 9-splice site sequences
of the introns. It rather is also dependent on exon recognition and
additional splicing factors. The c.2229C.T mutation is located
in a potential exonic splice enhancer (ESE) motif [12]. The T-
allele eliminates a potential binding site for the splicing factor
ASF/SF-2 and it potentially increases the affinity for SC35, a
different auxiliary splicing protein (Figure S5).
The c.2229C.T variant affects a CpG dinucleotide, which are
known to have a relatively high mutation rate in mammals.
Interestingly, the same C.T transition must have independently
occurred more than once during evolution as several species
including humans have the T-allele at this position, which is found
in cattle with degenerative axonopathy. Apparently, in these other
species the splicing of MFN2 transcripts functions normally. This
further highlights the complexity of exon recognition in higher
eukaryotes.
In human patients with hereditary diseases, other examples of
translationally silent exonic mutations that affect the splicing were
reported before [13,14]. As these mutations cannot be as easily
recognized as non-synonymous mutations there is always the risk
that they remain unidentified. This becomes especially important
in next generation sequencing projects, where typically thousands
of genomic variants are initially identified. Currently, many
researchers consider only the non-synonymous variants in such
projects as promising candidates [15]. Thus other types of
mutations such as translationally silent ESE mutations may easily
be missed. Therefore, bioinformatic tools that can identify
potentially deleterious mutations with an effect on splicing will
be very important to make optimal use of the new large-scale re-
sequencing approaches.
The c.2229C.T mutation affects the splicing of the MFN2
transcripts. Our findings indicate that in homozygous mutant
animals, about 20% to 45% of the MFN2 transcripts retain the last
intron. These aberrant transcripts contain an open reading frame
lacking the last 22 codons (Figure S3). The wildtype MFN2 is a
757 amino acid transmembrane protein anchored in the outer
mitochondrial membrane [16,17]. The vast majority of the protein
including N-terminus and C-terminus are located in the cytoplasm
and only two amino acids between the transmembrane domains
are located inside the mitochondria. The protein can form homo-
and heterodimers via the interaction of its two heptad repeat
regions that can make up coiled-coil structures [18].
Mitochondria are very dynamic organelles that continuously
undergo fusions and fissions. Dimerization mediated by MFN2 is
an essential step in the tethering and subsequent fusion of
mitochondria [19]. Additionally, MFN2 is present in the
endoplasmic reticulum (ER) and required for tethering of
mitochondrial and ER membranes [20]. About 60 protein-
changing MFN2 mutations have been described in human patients
with Charcot-Marie-Tooth disease 2A2 [21–25], which is
characterized by axonal degeneration that affects peripheral
neurons with the longest axons. However, in contrast to
degenerative axonopathy in Tyrolean Grey cattle, no axonal
degeneration of the central nervous system has been described in
humans. The pathophysiology of this degenerative axonopathy in
cattle remains unknown. In mouse models, Mfn2 mutations cause
massive axonal degeneration in motor nerves and impair
mitochondrial fusion leading to uneven distribution of mitochon-
Figure 2. Genome-wide association and homozygosity mapping of Tyrolean Grey cattle degenerative axonopathy. (A) Case-control
genome-wide association analysis shows a significant association to SNPs on chromosome 16. (B) Single SNP association results across BTA 16.
(C) Homozygosity mapping of the degenerative axonopathy mutation. The analysis of SNP genotypes from 14 affected calves indicated an extended
shared homozygous region of 2.9 Mb. One recombinant chromosome from a carrier animal further narrowed the critical interval to 1.9 Mb. (D) Gene
content of the corresponding human chromosome 1 segment.
doi:10.1371/journal.pone.0018931.g002
Table 1. Association of the MFN2 mutation with the
degenerative axonopathy phenotype.
Tyrolean Grey cattle Other breeds
MFN2
affected
(n=44)
carrier
a
(n=45)
controls
(n=396)
controls
(n=83)
c.2229C.TC C 1
b 358 83
CT 44 38
TT 44
aCattle recorded as parent of affected calves.
bFor this animal only one single suspicious calf was recorded by the breeding
organization and the diagnosis of this calf had not been confirmed by
necropsy. Genotyping of additional flanking markers revealed that this animal
did not carry the disease-associated haplotype. Therefore, the reported calf
most likely represented a phenocopy and the parent is indeed free of the
deleterious mutation.
doi:10.1371/journal.pone.0018931.t001
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how mitochondrial fusion affects neuronal function and axonal
survival remain unclear [28]. It has been hypothesized that defects
in mitochondrial fusion result in irregular distribution of
mitochondrial DNA between organelles leading to loss of
mitochondrial DNA and impairment of oxidative phosphorylation
[21]. Damaged mitochondria are abnormally shaped and
incorrectly transported leading to mitochondrial accumulations
within axons. Accordingly, in human patients with Charcot-
Marie-Tooth disease 2A2 due to MFN2 mutations, axonal
degeneration is associated with mitochondrial changes as shown
by electron microscopy. These include focal mitochondrial
accumulations within distal axons and degeneration with mito-
chondrial swelling, condensation and irregularities of mitochon-
drial membranes [24,25,29]. Although we did not assess
ultrastructural changes morphometrically in the present study,
Figure 3. MFN2 transcript analysis. (A) Northern blot using a full length MFN2 cDNA probe. Note the additional band of 5.8 kb in all examined
tissues of an affected calf. (B) Relative MFN2 transcript levels. The MFN2 expression levels were normalized to BM2 expression. For the affected calf the
relative expression levels of the wildtype and mutant transcript are indicated. (C) Bovine MFN2 gene organization. The 2229C-wildtype allele gives
rise to a transcript, which is spliced as expected. The mutant 2229T-allele leads to partial retention of intron 19. Thus from the mutant allele tissue-
specific varying fractions of wildtype transcript and an aberrant transcript encoding a truncated MFN2 protein are expressed.
doi:10.1371/journal.pone.0018931.g003
Figure 4. Western immunoblot analysis of MFN2. Extracts from
the cerebral and cerebellar cortex of a degenerative axonopathy
affected calf and a healthy control calf were analyzed. In the samples
from the affected calf a weak additional MFN2 band of slightly lower
molecular mass (83.7 kDa, arrow) as compared to the full-length wild-
type protein (86.3 kDa) is visible. Conversely, in the healthy control only
the wild-type MFN2 is detected. Molecular masses of the size standard
are indicated on the right.
doi:10.1371/journal.pone.0018931.g004
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affected animal is compatible with the contention that the reported
mutation had an effect on mitochondrial shape.
The cattle MFN2 mutation truncates the last 22 amino acids.
We do not know whether this mutant protein is further modified in
vivo. One of the human Charcot-Marie-Tooth mutations,
p.G751X, is predicted to truncate the last seven amino acids of
the protein and confirms that these residues are essential for
normal MFN2 function [25]. All the reported human MFN2
mutations act in an autosomal dominant mode of inheritance,
whereas the bovine mutation is inherited recessively. We think that
this is due to the fact that from the mutant bovine allele only a
relatively small fraction of aberrant protein is expressed. Thus,
assuming equal translation efficiencies of the different transcripts,
even homozygous mutant Tyrolean Grey cattle produce more
than 50% of the normal amount of wildtype protein and only
20%–45% of the mutant protein. This may explain that the
degenerative axonopathy manifests only in homozygous mutant
animals. Additionally, cattle are not as intensively monitored as
humans. Therefore, it is quite possible that very mild neurological
symptoms in heterozygous mutant animals have not been
recognized in the past.
Our genotyping results of 396 healthy Tyrolean Grey cattle
indicate that the current carrier frequency in this population is
close to 10%. This number may be somewhat inflated as breeders
submit preferentially descendants of known carriers to genetic
testing. However, pedigree analysis reveals that 7.2% of the
genome in Tyrolean Grey cattle born 2004–2008 is derived from
the important ancestor that has transmitted the deleterious allele
to most of the cases. This animal was traced in 90.2% of all
pedigrees. Our findings emphasize how the breeding practice in
modern livestock populations can lead to high frequencies of
deleterious alleles within a few generations. Therefore, it is
essential that domestic animal populations with small effective
population sizes are continuously monitored for the appearance of
recessive defects, so that selection against the deleterious alleles can
be implemented as early as possible.
In conclusion, we have identified a translationally silent variant
in a potential exonic splice enhancer of the bovine MFN2 gene as
the causative mutation for a splice defect. The knowledge on
MFN2 mutations in human Charcot-Marie-Tooth patents suggests
that this splice defect is also responsible for the inherited
degenerative axonopathy in Tyrolean Grey cattle, although we
have no functional proof for this claim. Our finding enables
genetic testing and the eradication of this genetic disease from the
breeding population.
Materials and Methods
Animals
The animal experiments in this study were carried out under
permit 58/09 (canton of Bern) and in strict accordance with all
regulations for the work with animals at the University of Bern.
We collected samples from 44 degenerative axonopathy affected
calves (22 male, 27 female) from different farms. The phenotype
classification was primarily based on the owners’ reports. Some
affected animals were seen by a veterinarian and for five cases
necropsy results and a histopathological examination were
available. Additionally, we collected 45 samples recorded as
parents (21 sires, 24 dams) of affected offspring and 396 healthy
Tyrolean Grey cattle resulting in a total of 485 samples from this
breed. For the association study we also used 83 healthy cattle
from 10 genetically diverse Bos taurus breeds.
Neuropathological examination
Brain, spinal cord and tissue samples from the peripheral nerves
and skeletal muscle were immersion fixed in 4% neutral buffered
formaldehyde. Representative tissue samples were processed,
embedded in paraffin, sectioned at 5 mm and stained with
hematoxylin and eosin (HE). Selected sections of the brain and
spinal cord were stained with Luxol fast blue HE and modified
Bielschowsky stain.
DNA and RNA extraction
Genomic DNA was isolated from semen or tissue using the
Nucleon Bacc2 kit (GE Healthcare). Total RNA was isolated using
Trizol reagent according to the manufacturer’s instructions
(Invitrogen).
Mapping of the degenerative axonopathy mutation
Genomic DNA from 14 cases, 27 controls, and 18 carriers was
genotyped using Illumina’s BovineSNP50 BeadChip with 54,001
SNPs [30,31]. The results were analyzed with PLINK [32]. After
removing 1,588 SNPs with low genotyping success (failed calls .
0.1) the average genotyping rate per individual was 99.9%. A total
of 18,239 SNPs had a minor allele frequency (MAF) ,0.1 and
Figure 5. Electron micrographs of striated muscle fibers. (A) Muscle fibers of healthy calf contain rigorously oriented, elongate mitochondria.
(B) Uneven space between myofibrils in striated muscle of affected calf displays branched mitochondria. (scale bar =0.5 mm)
doi:10.1371/journal.pone.0018931.g005
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options –assoc was applied. Genome-wide corrected empirical p-
values were determined applying the max(T) permutation
procedure implemented in PLINK with 10,000 permutations.
To identify extended homozygous regions with allele sharing
across all affected animals the options –homozyg-group and –
homozyg-match were applied. Tracing of the disease-associated
haplotype in parents of non-genotpyed cases was performed with
FORTRAN software developed for that purpose. Homozygosity of
carriers for the alternative allele was used to fine-map the critical
interval as described before [33]. All given positions correspond to
the Btau4.0 cattle genome assembly. The corresponding human
chromosome segment (build 37.1) was identified by BLASTN
searches of bovine SNP flanking sequences to the human genome
sequence.
Genomic DNA analysis
Genomic DNA from 3 cases, 2 carriers, and 3 unrelated
healthy calves, which were assumed to be homozygous free of the
mutation were used for mutation analysis. PCR products were
amplified using AmpliTaqGold360Mastermix (Applied Biosys-
tems). PCR products were directly sequenced on an ABI 3730
capillary sequencer (Applied Biosystems) after treatment with
exonuclease I and shrimp alkaline phosphatase. Sequence data
were analyzed with Sequencher 4.9 (GeneCodes). The bovine
reference genome sequence contained a gap in the region of the
MFN2 gene. We determined a complete and contiguous
sequence of the bovine MFN2 gene as well as of two alternatively
spliced transcripts and deposited these sequences in the EMBL
database (accessions FN868562–FN868564). Potential exonic
splice enhancer (ESE) motifs were detected with ESE finder 3.0
[34].
Northern Blot
For the Northern blot 20 mg total RNA of various tissues derived
from an affected as well a healthy control animal were denatured by
Glyoxal/DMSO and separated by gel electrophoresis. RNA was
transferred to Hybond
TM-N+ membrane (GE Healthcare) by
capillary blotting. Hybridization was carried out as previously
described [35] using either a
32P-labeled full length MFN2 cDNA
probe or a probe containing nt 24-670 of the bovine beta-2-
microglobulin cDNA (B2M) (accession NM_173893) as a loading
control. The density of the individual bands was measured on an
AlphaImager
TM gel documentation system (Cell Biosciences).
RT-PCR
We performed cDNA synthesis using SuperScriptIII (Invitro-
gen) and an oligo d(T)24V primer. For the RT-PCR we used
SequalPrep Long Polymerase (Invitrogen), a forward primer
located in exon 2 (59-GCGGAGTCATTCAGTAGCCATCTT-
39), and a reverse primer located in the 39-UTR of exon 20 (59-
AGTTGGAAGGTCTTCCTGCAACAG-39) to amplify the
2521/2606/3726/3811 bp products containing the entire MFN2
open reading frame. These products correspond to wildtype
isoforms 1/2, and mutant isoforms1/2 including intron 19,
respectively. To confirm the identity of the alternatively spliced
transcripts in the affected animal we sequenced the obtained PCR
products with internal primers located in exon 19, intron 19 and
exon 20, respectively. Furthermore we performed RT-PCR using
a forward primer located in exon 15 (59-TGATGGGCTACAGT-
GACCAG-39) and a reverse primer located in intron 19 (59-
ATGGTCTCAGCAGGAGATGG-39) to confirm the retention of
intron 19 in the affected calf.
Western immunoblot
Nervous tissue samples of the affected calf and the control calf were
homogenized at a ratio of 1:10 (w/v) in 5% (v/v) glucose solution
using a Fastprep blender (Bio-Rad). Proteins were extracted from the
homogenates by boiling in equal amounts of La ¨mmli Buffer (Bio-Rad),
separated by SDS-PAGE in an 8% hand-casted acrylamide gel (7 cm
6 6 cm) and transferred to a polyvinylidene fluoride membrane.
Next, MFN2 was detected by using a polyclonal rabbit-anti-MFN2
(N-terminal) serum (Sigma), a goat anti-rabbit IgG-HRP conjugate
(DAKO) as secondary antibody and a chemiluminescence-based
detection system (ECL plus, GE healthcare). A molecular mass
standard (See-Blue, Invitrogen) was included in one lane of the gel.
Electron microscopy
Samples from striated muscles, peripheral nerves, kidney,
salivary glands, brain and spinal cord were collected immediately
after euthanasia. Tissue cubes of 1-2 mm edge length were
immersion fixed at room temperature for 2 h. The fixative was
made up of 2.5% glutaraldehyde in 0.1 M cacodylate buffer with
2 mM CaCl2, pH 7.4. After two washing steps in the same buffer,
samples were postfixed with 1% (w/v) OsO4 in cacodylate buffer
for 2 h at 4uC, washed again, dehydrated and embedded in an
Epon-Araldite mixture according to standard protocols. Ultrathin
sections of 70 nm in thickness were double stained with 0.5%
uranyl acetate and 0.5% lead citrate and examined in a Zeiss
transmission EM 109 at 50 kV.
Supporting Information
Figure S1 Pedigrees of families in study. Filled symbols represent
degenerative axonopathy affected calves, open symbols represent
normal cattle. DNA samples were available only for the numbered
individuals. Animals genotyped on the SNP chip are indicated by
asterisks. Parents of affected offspring and animals genotyped as
carriers of the MFN2 c.2229C.T mutation are shown with half-
filled symbols. The mutation was predominantly distributed by
three offspring (A, B, C) of a single cow. Most of the mothers of
affected calves are related to these three offspring and the number
of generations is indicated. A recent pedigree (D) indicates that the
causative mutation might be older.
(PDF)
Figure S2 Northern blot using a full length TARDBP cDNA
probe. The expression of TARDBP is similar between tissues from
an affected and a control calf. Normalization was performed by
hybridization with a B2M probe.
(PDF)
Figure S3 Multispecies alignment of MFN2 protein sequences.
Sequences correspond to Genbank accessions from self-predicted
(cattle), NP_055689 (human), XP_544564 (dog), NP_573464 (mouse),
NP_570964 (rat), NP_001084869 (Xenopus), NP_001121726 (zebra-
fish). Note the extremely high sequence conservation from human to
zebrafish. Important functional motifs as annotated in the Uni-
ProtKB/Swiss-Prot accession O95140 are highlighted in color. The x-
ray structure of a partial human MFN1 protein suggests that the C-
termini of mitofusins utilize a heptad repeat region (HR2) to form
dimeric antiparallel coiled coils. The HR2 region of MFN2 contains
amino acids 693–754. The aberrant MFN2 transcript observed in
affected Tyrolean Grey cattle encodes a protein lacking the last 22
amino acids (boxed). Thus the aberrant MFN2 protein lacks a large
part of the functionally important HR2 domain.
(PDF)
Figure S4 Sequence analysis of MFN2 transcripts from a
heterozygous carrier animal. (A) We amplified a cDNA fragment
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PLoS ONE | www.plosone.org 8 April 2011 | Volume 6 | Issue 4 | e18931containing the retained intron from a carrier animal by using a
forward primer located in intron 19 and a reverse primer located
in exon 20 on oligo-dT primed cDNA. The sequence analysis of
this RT-PCR product shows only the mutant T-allele at the
c.2229 position. This indicates that the splicing aberration occurs
only in transcripts from the mutant allele and not in transcripts
from the wildtype allele. (B) A sequencing reaction using the same
primers on a genomic PCR product from the same carrier animal
confirms the presence of both alleles on the genomic DNA.
(PDF)
Figure S5 Sequence context of the c.2229C.T polymorphism.
(A) The last 30 nucleotides of intron 19 (lowercase letters) and the
first 70 nucleotides including the stop codon of exon 20 (uppercase
letters) are shown. The candidate causative mutation is located at
the 25th base of exon 20. (B) Analysis of exonic splice enhancer
elements (ESEs). The c.2229C.T mutation eliminates a potential
binding site for the SF2/ASF splicing factor and increases the
binding score for the splicing factor SC35. The binding scores for
the different splicing factors for the first 40 nucleotides of exon 20
were calculated with the program ESE Finder 3.0. Binding scores
for different splicing proteins are based on different weight
matrices and cannot be compared directly to each other.
(PDF)
Table S1 Polymorphisms and genotypes of 8 Tyrolean Grey
cattle in the region of the MFN2 gene.
(XLSX)
Video S1 Ataxia in a Tyrolean Grey calf affected by
degenerative axonopathy.
(WMV)
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